ACGT will join over 300 organization at the annual Rally for Medical Research Day on Capitol Hill in Washington on September 22nd to urge Congress to improve medical research funding. Read More
US News and World Report recently released their annual rankings of the best hospitals for cancer and many ACGT researchers and Scientific Advisory Council members Read More
ACGT Researchers Meenakshi Hegde and Nabil Ahmed have published a preclinical study on the potential to improve glioblastoma recurrence Read More
In 2012, Bob Levis, an Allentown, Pennsylvania resident, believed he had come to the end of his life. Diagnosed in 2002 with chronic lymphocytic leukemia, … Read More
“They took my cancer cells and irradiated them, and then injected them back into my body so my immune system would kick in,” Morrow said. Read More
I am an almost five year survivor of Stage IV NSCLC, adenocarcinoma. I attribute this amazing achievement to the grace of God, aggressive treatment and a “no stone left unturned” attitude. This attitude led me years ago to ACGT and the pioneering work of people like Dr. Jack Roth. Read More
2015 – 2016 ACGT Young Investigator, Yvonne Chen, MS, PhD, speaks about using engineered T-cells to cure leukemia in this video from May 2016. Great progress … Read More
On Saturday, June 25, 2016, a record number of swimmers, boaters, kayakers and land volunteers participated in the Tenth Annual Swim Across America Greenwich-Stamford Open … Read More
Dr. Laurence Cooper, Alliance for Cancer Gene Fellow speaks about the breakthroughs in Immunotherapy to destroy cancer and translate ideas from the bench to the … Read More
The mission of ACGT is to seek out and support revolutionary scientific research into the causes, treatment and prevention of all types of cancer using cells and genes as medicine.
Cell and gene therapies are destroying tumors every day in the laboratory and in human trials, targeting only the cancer with few side effects to healthy tissue. ACGT’s rigorous grant review process, under the guidance of a preeminent Scientific Advisory Council, have resulted in some of the most successful breakthroughs in the history of cancer treatments and led to many patients in complete remission.
100% of our funding supports innovation and translational science that is proving again and again to offer better treatment options than the traditional therapies of chemotherapy, surgery and radiation. Every donation brings us closer to saving lives and changing the way we treat cancer forever.